Michael E. Wechsler

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

Mario Castro, James Zangrilli, Michael E. Wechsler et al. · The Lancet Respiratory Medicine · 2015 · 1.2K citations

Life Sciences, Immunology, Pharmacotherapy +11

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

Michael E. Wechsler, Praveen Akuthota, David Jayne et al. · New England Journal of Medicine · 2017 · 1.1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

Andrew Menzies‐Gow, Jonathan Corren, Arnaud Bourdin et al. · New England Journal of Medicine · 2021 · 967 citations · Full text

Life Sciences, Immunology, Internal Medicine +6

Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma

Yvonne J. Huang, Craig E. Nelson, Eoin Brodie et al. · Journal of Allergy and Clinical Immunology · 2010 · 696 citations · Full text

Life Sciences, Immunology, Microbiology +14

Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial

Mario Castro, Adalberto Sperb Rubin, Michel Laviolette et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 685 citations

Medicine, Clinical Sciences, Surgery +17